dihydroergotamine mesylate

Product NDC
25021-609
11-digit product format
250210609
Labeler code
25021
Product ID
25021-609_313efcad-0c65-49cb-940b-b4e6de4c6dff
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
dihydroergotamine mesylate
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Labeler
Sagent Pharmaceuticals
Application
ANDA207264
Marketing category
ANDA
Marketing start
2022-09-15
Marketing end
0000-00-00
Substance
DIHYDROERGOTAMINE MESYLATE
Active strength
1 mg/mL
Pharmacologic classes
Ergotamine Derivative [EPC], Ergotamines [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
25021-609DIHYDROERGOTAMINE MESYLATE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]8Legacy NDC20240711_0f110b91-9c2b-4b9d-9bc9-172e56307769.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
25021-609-01250210609015 VIAL in 1 CARTON (25021-609-01) > 1 mL in 1 VIAL5 vial2022-09-150000-00-00NoNoCurrent
25021-609-022502106090210 VIAL in 1 CARTON (25021-609-02) > 1 mL in 1 VIAL10 vial2022-09-150000-00-00NoNoCurrent